B-SOFT Co.,Ltd. (SHE:300451)
China · Delayed Price · Currency is CNY 4.610
+0.040 (0.88%)
Apr 16, 2026, 3:04 PM CST
B-SOFT Revenue
In the year 2025, B-SOFT had annual revenue of 1.05B CNY, down -26.07%. B-SOFT had revenue of 190.03M in the quarter ending December 31, 2025, a decrease of -25.19%.
Revenue
1.05B
Revenue Growth
-26.07%
P/S Ratio
6.77
Revenue / Employee
291.01K
Employees
3,614
Market Cap
7.12B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 1.05B | -370.92M | -26.07% |
| Dec 31, 2024 | 1.42B | -193.23M | -11.96% |
| Dec 31, 2023 | 1.62B | 88.73M | 5.81% |
| Jan 1, 2023 | 1.53B | -371.84M | -19.58% |
| Jan 1, 2022 | 1.90B | 266.14M | 16.30% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| WuXi AppTec | 43.42B |
| Shenzhen Mindray Bio-Medical Electronics | 33.28B |
| Jiangsu Hengrui Pharmaceuticals Co.,Ltd | 31.63B |
| Yixintang Pharmaceutical Group | 17.41B |
| Truking Technology | 5.55B |
| Cisen Pharmaceutical | 3.44B |
| Sichuan Biokin Pharmaceutical | 2.52B |
| Shandong Wit Dyne Health | 2.36B |